FDA — authorised 27 January 1989
- Application: NDA018554
- Marketing authorisation holder: SCHERING
- Local brand name: EULEXIN
- Indication: CAPSULE — ORAL
- Status: approved
FDA authorised Antiandrogen on 27 January 1989
Yes. FDA authorised it on 27 January 1989.
SCHERING holds the US marketing authorisation.